ArticleJMIR research protocols2017

Use of the Total Cancer Care System to Enrich Screening for CD30-Positive Solid Tumors for Patient Enrollment Into a Brentuximab Vedotin Clinical Trial: A Pilot Study to Evaluate Feasibility.

Bin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.